Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years Old

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age4-6
SponsorHasanuddin University

About this trial

This is a study to evaluate the effects of a prebiotic, AHCC, a standardized extract of cultured Lentinula edodes mycelia, on immunologic markers and the incidence of respiratory tract infections in children.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Children aged 4-6 years old at the time of enrolment

Good nutritional status with weight-for-height > -2, and height-for-age z-score > -2 based on WHO growth standards

Infants in a group setting (daycare centers).

No congenital disorder

Disqualifiers

Presence of chronic illnesses or conditions (congenital disorder, genetic syndromes, congenital heart disease, chronic renal failure, cystic fibrosis, etc)

Children who have participated in another clinical intervention study within the past 30 days.

Children who are likely to be transferred to another facility that is not part of the study before completing the follow-up period

Trial design

Design model

Parallel

Treatments tested in this trial

  • a prebiotic, that us a standardized extract of cultured Lentinula edodes mycelia

    Dietary supplement

    Subjects will be administered dextrin including AHCC.

  • Placebo (dextrin)

    Dietary supplement

    Subjects will be administered dextrin alone (placebo)

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Control arm of the intervention studyPlacebo comparator 1 intervention
Group B: Active arm of the intervention studyOther 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of Respiratory Tract Infection

the number incidence of infections, specifically respiratory tract infection, by looking at the number of febrile days (\>37.5 ◦C) during the test period.

Time frame
3 months

Secondary outcomes

1

additional immunological effects

immunomodulatory effects of AHCC, we will be checking serum IFN-γ as a biomarker of immunity at baseline and 3 months after AHCC using enzyme-linked immunosorbent assay (ELISA).

Time frame
3 months
2

additional nutritional effect- WAZ score

changes in weight-for-age z-score as sign of growth and nutritional status.

Time frame
3 months
3

additional nutritional effect- Weight in gram

changes in weight in gram as sign of growth and nutritional status.

Time frame
3 months
4

additional nutritional effect- HAZ score

changes in height-for-age z-score as sign of growth and nutritional status.

Time frame
3 months

Other outcomes

1

compliance and adherence rates

evaluate compliance and adherence rates to the intervention and their association with study outcomes. The secondary outcome measures include: * The count of days missed from Daycare Centers due to symptoms of the common cold symptoms * The duration of fever and cough during viral infections * Any side effects linked to the consumption of AHCC.

Time frame
3 months
2

Caregiver-reported adherence

Adherence monitored through daily intake logs, home visits, and telephone follow-ups

Time frame
3 months
3

Incidence of adverse events

Adverse events data collection during and post intervention

Time frame
Baseline through Month 8 (including 5 months post intervention follow up)

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hasanuddin University

Lead sponsor

Amino Up Co. Ltd., Sapporo, Japan

Collaborator

This trial is not recruiting at the moment. You can still explore other options: